Skip to main content
  • Study protocol
  • Open access
  • Published:

Game-based health education to improve ART adherence of newly diagnosed young people with HIV: protocol for a stepped-wedge design randomized controlled trial

Abstract

Background

Antiretroviral therapy (ART) is one of the most effective ways for HIV-infected to treat AIDS. However, it is difficult to start ART among young people those newly diagnosed HIV-infection in China, and their adherence to ART is poor. We have designed an AIDS educational game called AIDS Fighter · Health Defense, which could improve the AIDS-related knowledge and has the potential to improve AIDS prevention ability of young students. In this study, AIDS Fighter · Health Defense will be used with newly diagnosed young people with HIV to evaluate the education effect of the game in improving ART adherence.

Design

A stepped-wedge design randomized controlled trial will be conducted to confirm the education effect of AIDS Fighter · Health Defense on improving ART adherence of newly diagnosed young people with HIV, and to verify when to start game-based health education could be more effective for newly diagnosed young people with HIV.

Methods

Participants will receive AIDS education from health workers and start ART when diagnosed with HIV and assigned into four groups randomly. The first step group to the fourth step group will receive AIDS Fighter · Health Defense in turn at the star of ART, one week, one month and three months after the start of ART. The primary outcomes are medication adherence, CD4( +) T cell count, and HIV viral load. The secondary outcomes are ART-related knowledge, ART-related skills, psychological resilience, and self-discrimination. Assessments will be completed before the intervention and one week, first month, and third month of the intervention, and then a one-year follow-up evaluation will be conducted after the intervention.

Discussion

AIDS Fighter · Health Defense may be an effective approach to help newly diagnosed young people with HIV to improve ART adherence. A stepped-wedge design randomized controlled trial of this study may find the optimal time of AIDS education to improve ART adherence of newly diagnosed young people with HIV.

Registration number

Chinese Clinical Trial Registry: ChiCTR2200059766, registered 11 May 2022. http://www.chictr.org.cn/showproj.aspx?proj=169420

Background

Antiretroviral therapy (ART) is one of the most effective treatments for HIV-infected [1]. There is a global consensus that adherence to ART is critical to the success of HIV treatment [2, 3]. Good ART adherence of HIV-infected could help them maintain viral suppression [4], reduce HIV contagiousness [5], maintain high CD4( +) T cell count and reduce the incidence of AIDS-related complications [6]. In China, 92.6% of people live with HIV (PLHIV) had access to ART by the end of 2021 [7]; And a study of 1198 PLWH from Guangxi, China, showed 80.3% of people receiving ART had optimal medication adherence [8]. While some progress has been made in ending the AIDS epidemic, another point of concern should be noted, namely the persistence of ART adherence [9]. A meta-analysis of ART adherence in China showed that, the mean ART adherence among HIV-infected in China was 81.1% at one week of ART initiation, 80.9% at one month of ART initiation, and dropped to 68.3% at three months of ART initiation [10]. Which means that a sharp decline occurred within three months, making it more difficult to adhere to long-term antiviral treatment.

Adolescents have lower adherence rates than children and adults [11,12,13]. According to a Ugandan study, only 63.4% of young people are adhered to their ART consistently [14]. In 2021, there are over 1.14 million cases of HIV infection, of which young people aged 15–25 account for about 36% [15, 16]. Even among those newly infected, approximately 28% are young people [17]. Moreover, it is difficult for newly diagnosed young people with HIV to start ART. A survey showed that only 39.5% of young people infected with HIV could initiate ART in a timely manner [18], and ART adherence was poor after initiation [19]. Lack of ART related knowledge is one of the important reasons affecting the medication behavior of young people [20]. AIDS health education has been shown to be an effective way to improve the self-management ability of young people infected with HIV [21]. However, there is a lack of health education on ART adherence among newly diagnosed young people with HIV [22].

Game-based health education has been widely used in disease education, like diabetes [23], breast cancer [24], cardiovascular disease [25], etc., and has been shown to have good educational effects. Game-based health education on AIDS was mainly aimed at young people [26], including HIV-infected adolescents, gay men, and other high-risk groups [27, 28]. The goals of education were to increase the adherence with pre-exposure prophylaxis (PrEP) and ART [29, 30], promote AIDS screening [31], reduce risky sexual behaviors and avoid drug and alcohol abuse [32,33,34]. However, there were few studies on game-based health education on ART in newly diagnosed young people with HIV.

We have developed an AIDS educational game called AIDS Fighter· Health Defense, which has seven levels with difficulty increasing as the levels continue. The storyline of the game is that HIV has invaded the human body, and players need to fight to clear HIV. Players are required to collect ART medicine and condoms, avoid HIV, alcohol and drug, take ART medicine regularly, and answer questions about ART. More information about the game can be found in our published studies [35, 36]. It had been shown that the game can improve the AIDS-related knowledge and has the potential to improve AIDS prevention ability of young students. Therefore, we believe that AIDS Fighter· Health Defense could be an effective, large-scale intervention tool for AIDS health education. In this study, AIDS Fighter · Health Defense will be used with newly diagnosed young people with HIV to evaluate the education effect of the game in improving ART adherence.

Below we describe the protocol of our stepped-wedge design randomized controlled trial to evaluate the effect of the game to improve the ART adherence of newly diagnosed young people with HIV. The trial is a 3-month game-based intervention, and the game includes components designed to increase ART adherence, ART knowledge, ART skills, psychological resilience and perceived benefits, and to reduce self-discrimination, anxiety and depression.

Methods/Design

Study design

A stepped-wedge design randomized controlled trial with four groups will be conducted. Which is a relatively new research design [37]. The design included an initial phase in which no groups are exposed to the intervention. Subsequently, at fixed time intervals (“steps”), a group (or set of groups) is randomly crossed over from the control to the intervention under evaluation. The start of the intervention is different for each group, and this design helps to verify the effect of intervention timing on intervention effect.

Participants will be assigned to the four groups in 1:1:1:1 randomly. There is no dedicated control group in this study, and each step group will receive AIDS Fighter · Health Defense intervention in turn as the trial progress (see Fig. 1 for study workflow diagram). The group which has not received the intervention will be treated as the control group. Data collection will be conducted before and after intervention in each group. Participants in each group will be evaluated for medication adherence after the first week of intervention and the other outcomes will be evaluated after the first month and third month of intervention. Follow-up evaluations for the same outcomes will be performed at 6 and 12 months after the end of the intervention.

Fig. 1
figure 1

Study workflow diagram

Our hypotheses are:

  1. 1)

    Compared with the control groups, those in the AIDS Fighter · Health Defense intervention groups will have better ART adherence.

  2. 2)

    Varying time to receive AIDS Fighter · Health Defense intervention may lead to varying ART adherence.

  3. 3)

    AIDS Fighter · Health Defense could help newly diagnosed young people to maintain good long-term ART adherence.

Intervention design

Participants will receive AIDS education from health workers and start ART when diagnosed of HIV and randomly assigned into four groups. The first step group to the fourth step group will receive AIDS Fighter. Health Defense in turn at the start of ART, one week after the star of ART, one month after the star of ART and three months after the star of ART. Assessments will be completed before the intervention and after the first week, first month, and third month of intervention, and then a one-year follow-up evaluation will be conducted. The intervention design is shown in Fig. 2.

Fig. 2
figure 2

Intervention design

The first step intervention group

The first step group will receive the intervention of the educational game “AIDS Fighter · Health Defense” through WeChat at the time of enrollment and will be required to play the game at least 5 days a week and 20 min a day. During the 3-month intervention, participants will receive daily message notifications that inform users to play the game. A data management system will be used to monitor participants' time in the game and check details of the participant's use of the game.

The 2-4 step intervention group

The intervention of 2-4 step groups will be same as the first step intervention group, but the time they receive AIDS Fighter · Health Defense will be different. The second step group will receive the intervention 1 week after starting ART. The third step group will receive the intervention 1 month after starting ART. The fourth step group will receive the intervention 3 months after starting ART.

Recruitment of participants

The participants in this study are newly diagnosed young people with HIV. On-site recruitment will be conducted in AIDS clinics in Sichuan Province, China, where there are more than 10000 newly diagnosed people a year [38]. The inclusion criteria are: 1) diagnosed with HIV within 30 days [18]; 2) Young people aged 15 to 24; 3) Participants have clear consciousness and are able to read and communicate; 4) Participants were informed and voluntarily participated in the study; 5) Parental consent will be required to use the game if the participants are under 18 years old. And adults need to declare that they can use the game when they sign the informed consent. Those who have played similar games before will be excluded from the study. When the participants meet the inclusion criteria and agree to join this research, informed consent form will be signed.

Sample size calculation

The sample size was performed using the formula developed by Hemming [39]. The basic parameters for sample size calculation are based on the mean rate of adherence to ART at one week (81.1%) [9], assuming that the ART adherence of the intervention group would reaches 95%. The significance level of the test is α=0.05, the test power is 1-β=0.9, the coefficient of variation is ρ=0.15, the number of observation periods is t+1=7, the number of steps is t=6, the number of clusters is k=4, and N1 is calculated based on the sample size of the two groups. PASS software was used to calculate the initial sample size N1=220. According to the following formula:

$$\begin{array}{c}a=2k\left(t-\frac{1}{t}\right)\rho \left(1+\frac{t}{2}\right)\\ b={3N}_{1}\left(1-\rho \right)\rho \left(1+t\right)-2k\left(t-\frac{1}{t}\right)\left(1-\rho \right)\\ \begin{array}{c}c={3N}_{1}{\left(1-\rho \right)}^{2}\\ m=\frac{-b\pm \sqrt{{b}^{2}-4ac}}{2a}\\ N=\mathrm{m}\times \left(t+1\right)\times k\end{array}\end{array}$$

The required sample size for each group is calculated to be 140. Considering a potential 20% loss to follow-up, the final sample size for each group is 175, and the total sample size is 700.

Randomization and allocation concealment

Opaque envelopes will be used for randomization. Among the 700 envelopes, each envelope contained a note with the words "First Step Group", "Second Step Group", "Third Step Group" and "Fourth Step Group" (175 envelopes per group). An opaque envelope will be selected for the first time the participant enrolled, and they will be assigned to the corresponding group according to the envelope. The health workers for the AIDS education of newly diagnosed young people with HIV and the data analysts will be blinded for the allocation.

Quality control

Before the start of the trial, a non-disclosure agreement needs to be signed of all participants. They will be required to keep the contents of the intervention strictly confidential to ensure each group will receive the game at the specified time. Pre-testing will be conducted before the study begins, and the formal study protocol will be adjusted based on the results of the preliminary tests. After completing the research, each participant will receive a cash prize ranging from 20 to 100 RMB through a lottery.

Outcomes and data collection

The primary outcomes are medication adherence, CD4( +) T cell count, and HIV viral load. Medication adherence will be assessed by calculating the Medication Possession Ratio (MPR) [40], which will be calculated by the following formula:

$$MPR=\frac{days\mathrm{cov}eredwiththesumofdailydoses}{daysonART}$$

MPR is defined from 0 to 1, with closer to 1, indicating higher the adherence. In addition, The CPCRA 7-day recall adherence questionnaire [41] will be used to assess the medication adherence. Within the questionnaire, participants will be asked to recall the proportion of the prescribed medication in the past 7 days (100%, 80%, 50%, 20%, 0%) and the amount of missed medication in the past 3 days, 7 days and 30 days. CD4( +) T cell count, HIV viral load will be obtained by biochemical testing, and the testing will be carried out in a medical unit with testing qualifications. Participants with less than 400 copies/mL will be coded as being virally suppressed, while participants with viral loads of 400 or more copies/mL will be classified as not being virally suppressed [42].

Secondary outcomes are ART-related knowledge, ART-related skills, psychological resilience, self-discrimination. ART-related knowledge will be assessed by ART-related knowledge questionnaire [ 43], which was developed in Chinese with 21 items, each item has a correct answer and scored one point. A higher the score means higher the ART-related knowledge. ART-related skills will be assessed through a self-made questionnaire with 20 items, one point being allocated for a correct answer. The higher the score, means higher the ART-related skills. Psychological resilience will be assessed by the Resilience Scale for PLHIV [44], which was developed by our study team, including three dimensions and 29 items, one point for a correct answer. A higher the score means higher psychological resilience. Self-discrimination will be assessed by the Chinese version of Berger HIV stigma scale [45], which has 18 items, each item scored on a 4-point scale (from "strongly disagree" to "strongly agree" with a score of 1 to 4). A higher the score means higher self-discrimination.

Data analysis

All data will be uniformly entered by Epidata 3.1. And SPSS 26.0 statistical software will be used for analysis. The categorical data will be described by composition ratio and compared by chi-square test; quantitative data will be described by mean ± standard deviation and compared by Analysis of Variance; Generalized estimating equations models and linear mixed-effect (LME) models will be used to analyze the effect of game-based health education on ART medication adherence, CD4( +) T cell count, ART-related knowledge, psychological resilience, and self-discrimination. Mixed effects logistic regression models will be used for HIV viral load outcomes. Difference-in-difference analysis will be used to evaluate the change in the intervention groups excluding the effect of the changing over time. The differences are statistically significant with P ≤ 0.05.

Ethical approval and clinical trial registration

This study has been approved by the Ethics Committee of The Affiliated Hospital of Southwest Medical University, with the approval number KY2022163. And has been registered at Chinese Clinical Trial with the registration number ChiCTR2200059766. The Ethics Committee will audit the conduct of the trial, and have the right to make the decision to terminate the trial. The process will be independent from investigators and the sponsor. The study data will be uploaded to the China Clinical Trials Registry after the study is complete.

Discussion

The adherence of ART is fine in developed countries or areas, but which is poor in the southwest of China [46]. Many HIV-infected could not initiate ART immediately, with where the economy is relatively backward, people are poorly educated, and AIDS-related knowledge is lacking [47]. Especially for young people newly diagnosed with HIV in those areas, it is hard for them to start ART or adhere ART for long term [18, 19]. As many young people at the time they diagnosed with HIV, the immune damage was not severe and there were no clinical symptoms [48]. In addition, young people's social needs lead to their fear of being found to be taking ART medicine [49]. Therefore, it is needed to carry out HIV and ART-related health education among newly diagnosed HIV-infected people to improve their adherence of ART.

With the development of science and technology, AIDS health education has changed from traditional to modern ways. Among them, game-based intervention has become a significant method to change healthy behaviors [50, 51]. In our previous studies, an AIDS educational game called AIDS Fighter· Health Defense was developed, and a randomized controlled trial was conducted and proved that this game has a good education effect on AIDS prevention for young students. Students have good comments on the game and believe it could help them learn more about AIDS [36]. In this study, we would like to evaluate the effect of this game to improve ART adherence of young people newly diagnosed with HIV. And provide evidence for game-based education to improve ART adherence in China.

Someone diagnosed with HIV may be shocked and frustrated, especially young people who need to live with HIV for a long time [52]. It will take a while for them to adjust to the fact of being infected with HIV and accept to start ART [53], but they usually do not get that time and receive AIDS education and are required to start ART at the time of diagnosis in China [54]. This might be one of the reasons why adherence to ART sharply declines in the short term after initiation [55]. ART-related education could be more effective in maintaining long-term ART adherence in newly diagnosed people with HIV after they accept the fact of infection and are willing to learn AIDS-related knowledge [56, 57]. But it is limited to know how long it will take for young people infected with HIV to recover psychologically after infection. Therefore, we designed the protocol to find the optimal time point of intervention for ART adherence education. In this study, game-based education will be added to regular AIDS education to improve ART adherence of newly diagnosed young people with HIV. A stepped-wedge design randomized controlled trial will be conducted to evaluate the effect of game-based education and figure out when to start game-based education could be more effective. This could provide a reference for whether HIV-infected people need to be given some time for self-adjustment before receiving AIDS education and find out the difference in educational effect between different self-adjustment times.

We believe with the development of this study we will discover whether game-based education is effective in improving ART adherence in newly diagnosed young people with HIV. We could develop an AIDS education gamification method for China and other countries to improve the ART adherence of newly diagnosed young people with HIV. Beyond that, we will discover whether starting AIDS education at different times makes a difference and ascertain when to start AIDS education more effectively in China. This could be an innovation in AIDS education.

Availability of data and materials

The data collected in this study will be published in papers after the study is completed.

Abbreviations

AIDS:

Acquired Immune Deficiency Syndrome

ART:

Antiretroviral therapy

CPCRA:

Community Programs for Clinical Research on AIDS

HIV:

Human Immunodeficiency Virus

MPR:

Medication Possession Ratio

LME:

Linear mixed-effect

PLHIV:

People Living with HIV

PrEP:

Pre-exposure prophylaxis

WHO:

World Health Organization

References

  1. Maswabi K, Ajibola G, Bennett K, Capparelli EV, Jean-Philippe P, Moyo S, Mohammed T, Batlang O, Sakoi M, Lockman S, Makhema J, Lichterfeld M, Kuritzkes DR, Hughes MD, Shapiro RL. Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life. Clin Infect Dis. 2021;72(3):388–93. https://doi.org/10.1093/cid/ciaa028.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Progress report 2016: prevent HIV, test and treat all: WHO support for country impact. 2016. https://apps.who.int/iris/handle/10665/251713. Accessed 27 Nov 2022.

  3. Le PM, Nguyen PT, Nguyen HV, Bui DH, Vo SH, Nguyen NV, Nguyen TV, Tran AT, Le AD, Ha NM, Dao AT, Gilmour S. Adherence to highly active antiretroviral therapy among people living with HIV and associated high-risk behaviours and clinical characteristics: A cross-sectional survey in Vietnam. Int J STD AIDS. 2021;32(10):911–8. https://doi.org/10.1177/09564624211002405.

    Article  CAS  PubMed  Google Scholar 

  4. Agegnehu CD, Techane MA, Mersha AT, Atalell KA. Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. AIDS Behav. 2022;26(10):3327–36. https://doi.org/10.1007/s10461-022-03610-y.

    Article  PubMed  Google Scholar 

  5. Han WM, Law MG, Egger M, Wools-Kaloustian K, Moore R, McGowan C, Kumarasamy N, Desmonde S, Edmonds A, Davies MA, Yiannoutsos C, Althoff KN, Cortes CP, Mohamed TJ, Jaquet A, Anastos K, Euvrard J, Castelnuovo B, Salters K, Coelho LE, Ekouevi DK, Eley B, Diero L, Zaniewski E, Ford N, Sohn AH, Kariminia A, IeDEA collaboration. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV. 2021;8(12):e766–75. https://doi.org/10.1016/S2352-3018(21)00265-4.

  6. Chammartin F, Lodi S, Logan R, Ryom L, Mocroft A, Kirk O, d’Arminio Monforte A, Reiss P, Phillips A, El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C, Lundgren JD, Bucher HC, D:A:D Study Group. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study. Ann Intern Med. 2021;174(6):768–76. https://doi.org/10.7326/M20-5226.

  7. Gan XM, Zhao DC, Zhao Y, Ma Y, Wu YS, Dou ZH. Progress on national antiretroviral treatment program during 2003–2021 in China. Chinese J AIDS STD. 2022;28(06):642–6. https://doi.org/10.13419/j.cnki.aids.2022.06.04.

    Article  Google Scholar 

  8. Zeng C, Li X, Qiao S, Yang X, Shen Z, Zhou Y. Anticipated stigma and medication adherence among people living with HIV: the mechanistic roles of medication support and ART self-efficacy. AIDS Care. 2020;32(8):1014–22. https://doi.org/10.1080/09540121.2020.1728213.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bae JW, Guyer W, Grimm K, Altice FL. Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS. 2011;25(3):279–90. https://doi.org/10.1097/QAD.0b013e328340feb0.

    Article  PubMed  Google Scholar 

  10. Wang YY, Jin Y, Chen C, Zheng W, Wang SB, Ungvari GS, Ng CH, Zhang XD, Wang G, Xiang YT. Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China. AIDS Care. 2019;31(8):913–22. https://doi.org/10.1080/09540121.2018.1554238.

    Article  PubMed  Google Scholar 

  11. Kim SH, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014;28(13):1945–56. https://doi.org/10.1097/QAD.0000000000000316.

    Article  CAS  PubMed  Google Scholar 

  12. Boerma RS, Boender TS, Bussink AP, Calis JC, Bertagnolio S, Rinke de Wit TF, Boele van Hensbroek M, Sigaloff KC. Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis. Clin Infect Dis. 2016;63(12):1645–54.

    Article  PubMed  Google Scholar 

  13. Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. 2015;18(1):20049. https://doi.org/10.7448/IAS.18.1.20049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Brathwaite R, Ssewamala FM, Neilands TB, Okumu M, Mutumba M, Damulira C, Nabunya P, Kizito S, Sensoy Bahar O, Mellins CA, McKay MM. Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study. J Int AIDS Soc. 2021;24(6):e25756. https://doi.org/10.1002/jia2.25756.

    Article  PubMed  PubMed Central  Google Scholar 

  15. China CDC. Infectious Disease Prevention and Control. 2022. http://www.nhc.gov.cn/jkj/s2907/new_list.shtml?tdsourcetag=s_pcqq_aiomsg. Accessed 21 Aug 2022.

  16. Luanzhou Municipal People's Hospital. 17-year-old high school student AIDS positive: a relationship with life, even once is enough to destroy you. 2022. http://www.lxrmyy.net/index.php/cms/shows/48/2466.html. Accessed 21 Aug 2022.

  17. Joint United Nations Programme on HIV/AIDS. 2021 UNAIDS Global AIDS Update — Confronting inequalities, lessons for pandemic responses from 40 years of AIDS. 2021. https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update. Accessed 21 Apr 2022.

  18. Zhao Y, Wu Z, McGoogan JM, Sha Y, Zhao D, Ma Y, Brookmeyer R, Detels R, Montaner JSG. Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011–2015. Clin Infect Dis. 2019;68(1):43–50. https://doi.org/10.1093/cid/ciy400.

    Article  PubMed  Google Scholar 

  19. Zhu J, Yousuf MA, Yang W, Zhu Q, Shen Z, Lan G, Chen Y, Chen H, Fan W, Xing H, Shao Y, Ruan Y, Li L. Mortality and Attrition Rates within the First Year of Antiretroviral Therapy Initiation among People Living with HIV in Guangxi, China: An Observational Cohort Study. Biomed Res Int. 2021;10(2021):6657112. https://doi.org/10.1155/2021/6657112.

    Article  CAS  Google Scholar 

  20. Xu MJ. The Characteristics of Health Information Seeking and Sexual Behaviors in Adolescents Living with HIV. Beijing: Chinese Center for Disease Control and Prevention; 2019.

    Google Scholar 

  21. Abiodun O, Ladi-Akinyemi B, Olu-Abiodun O, Sotunsa J, Bamidele F, Adepoju A, David N, Adekunle M, Ogunnubi A, Imhonopi G, Yinusa I, Erinle C, Soetan O, Arifalo G, Adeyanju O, Alawode O, Omodunbi T. A Single-Blind, Parallel Design RCT to Assess the Effectiveness of SMS Reminders in Improving ART Adherence Among Adolescents Living with HIV (STARTA Trial). J Adolesc Health. 2021;68(4):728–36. https://doi.org/10.1016/j.jadohealth.2020.11.016.

    Article  PubMed  Google Scholar 

  22. Ross J, Ingabire C, Umwiza F, Gasana J, Munyaneza A, Murenzi G, Nsanzimana S, Remera E, Akiyama MJ, Anastos KM, Adedimeji A. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study. PLoS ONE. 2021;16(5):e0251645. https://doi.org/10.1371/journal.pone.0251645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Patel MS, Small DS, Harrison JD, Hilbert V, Fortunato MP, Oon AL, Rareshide CAL, Volpp KG. Effect of Behaviorally Designed Gamification With Social Incentives on Lifestyle Modification Among Adults With Uncontrolled Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(5):e2110255. https://doi.org/10.1001/jamanetworkopen.2021.10255.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bellens A, Roelant E, Sabbe B, Peeters M, van Dam PA. A video-game based cognitive training for breast cancer survivors with cognitive impairment: A prospective randomized pilot trial. Breast. 2020;53:23–32. https://doi.org/10.1016/j.breast.2020.06.003.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Davis AJ, Parker HM, Gallagher R. Gamified applications for secondary prevention in patients with high cardiovascular disease risk: A systematic review of effectiveness and acceptability. J Clin Nurs. 2021;30(19–20):3001–10. https://doi.org/10.1111/jocn.15808.

    Article  PubMed  Google Scholar 

  26. Brown M, O’Neill N, van Woerden H, Eslambolchilar P, Jones M, John A. Gamification and Adherence to Web-Based Mental Health Interventions: A Systematic Review. JMIR Ment Health. 2016;3(3):e39. https://doi.org/10.2196/mental.5710.

  27. LeGrand S, Muessig KE, McNulty T, Soni K, Knudtson K, Lemann A, Nwoko N, Hightow-Weidman LB. Epic Allies: Development of a Gaming App to Improve Antiretroviral Therapy Adherence Among Young HIV-Positive Men Who Have Sex With Men. JMIR Serious Games. 2016;4(1):e6. https://doi.org/10.2196/games.5687.

    Article  PubMed  PubMed Central  Google Scholar 

  28. LeGrand S, Muessig KE, Platt A, Soni K, Egger JR, Nwoko N, McNulty T, Hightow-Weidman LB. Epic Allies, a Gamified Mobile Phone App to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men and Young Transgender Women Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018;7(4):e94. https://doi.org/10.2196/resprot.8811.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Whiteley L, Mena L, Craker LK, Healy MG, Brown LK. Creating a Theoretically Grounded Gaming App to Increase Adherence to Pre-Exposure Prophylaxis: Lessons From the Development of the Viral Combat Mobile Phone Game. JMIR Serious Games. 2019;7(1):e11861. https://doi.org/10.2196/11861.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Casale M, Carlqvist A, Cluver L. Recent Interventions to Improve Retention in HIV Care and Adherence to Antiretroviral Treatment Among Adolescents and Youth: A Systematic Review. AIDS Patient Care STDS. 2019;33(6):237–52. https://doi.org/10.1089/apc.2018.0320.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Mejia CM, Acland D, Buzdugan R, Grimball R, Natoli L, McGrath MR, Klausner JD, McCoy SI. An Intervention Using Gamification to Increase Human Immunodeficiency Virus and Sexually Transmitted Infection Screening Among Young Men Who Have Sex With Men in California: Rationale and Design of Stick To It. JMIR Res Protoc. 2017;6(7):e140. https://doi.org/10.2196/resprot.8064.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Montanaro E, Fiellin LE, Fakhouri T, Kyriakides TC, Duncan LR. Using Videogame Apps to Assess Gains in Adolescents’ Substance Use Knowledge: New Opportunities for Evaluating Intervention Exposure and Content Mastery. J Med Internet Res. 2015;17(10):e245. https://doi.org/10.2196/jmir.4377.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gariepy AM, Hieftje K, Pendergrass T, Miller E, Dziura JD, Fiellin LE. Development and Feasibility Testing of a Videogame Intervention to Reduce High-Risk Sexual Behavior in Black and Hispanic Adolescents. Games Health J. 2018;7(6):393–400. https://doi.org/10.1089/g4h.2017.0142.

    Article  PubMed  PubMed Central  Google Scholar 

  34. DeSmet A, Shegog R, Van Ryckeghem D, Crombez G, De Bourdeaudhuij I. A Systematic Review and Meta-analysis of Interventions for Sexual Health Promotion Involving Serious Digital Games. Games Health J. 2015;4(2):78–90. https://doi.org/10.1089/g4h.2014.0110.

    Article  PubMed  Google Scholar 

  35. Tang J, Chen Y, Yu X, Ren J, Li M, Luo Y, Xie H, Wen J. AIDS fighter health defense: protocol for a randomized controlled trial to test a game-based intervention to improve adolescents’ AIDS prevention ability. BMC Infect Dis. 2021;21(1):469. https://doi.org/10.1186/s12879-021-06161-0.

  36. Tang J, Zheng Y, Zhang D, Yu X, Ren J, Li M, Luo Y, Tian M, Chen Y. Evaluation of an AIDS Educational Mobile Game (AIDS Fighter· Health Defense) for Young Students to Improve AIDS-Related Knowledge, Stigma, and Attitude Linked to High-Risk Behaviors in China: Randomized Controlled Trial. JMIR Serious Games. 2022;10(1):e32400. https://doi.org/10.2196/32400.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;6(350):h391. https://doi.org/10.1136/bmj.h391.

    Article  Google Scholar 

  38. Health Commission of Sichuan Province. Epidemic situation of notifiable infectious diseases in Sichuan Province in 2021. http://wsjkw.sc.gov.cn/scwsjkw/rdts/2022/1/17/5b6824066f174d06b337209df13c2d6c.shtml (2021). Accessed 27 Nov 2022.

  39. Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137–46. https://doi.org/10.1016/j.jclinepi.2015.08.015.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–22. https://doi.org/10.15386/mpr-1201.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21. https://doi.org/10.1086/339074.

    Article  PubMed  Google Scholar 

  42. Karver TS, Donastorg Y, Perez M, Gomez H, Galai N, Barrington C, Celentano D, Kerrigan D. Assessing the Relationship Between HIV Quality of Care and Treatment Literacy on ART Adherence and Viral Suppression Among Female Sex Workers Living in the Dominican Republic. AIDS Behav. 2022;26(9):3056–67. https://doi.org/10.1007/s10461-022-03647-z.

    Article  PubMed  Google Scholar 

  43. Fu Y, Yang H, Yuan XQ, Gao MX, Chen YX, Sun YH, Zhou MG, Liu ZY, Chen YJ, Xu F, Huang Y, Li XM. Analysis on the awareness rate of knowledge about antiviral therapy for HIV/AID. Chinese Journal of AIDS & STD. 2016;22(11):867–70. https://doi.org/10.13419/j.cnki.aids.2016.11.07.

    Article  Google Scholar 

  44. Yu XL, Wen J, Tang J, Zhu J, Xie H, Chen YH. The Preliminary Development of Resilience Scale for People Living with HIV. Chinese J AIDS & STD. 2021;27(8):852–5. https://doi.org/10.13419/j.cnki.aids.2021.08.13.

    Article  CAS  Google Scholar 

  45. Li Z, Wang KR, Sheng Y. The reliability and validity of the Chinese version of Berger HIV stigma scale. Chinese Journal of Nursing. 2015 Jul;50(7):882-85. CNKI:SUN:ZHHL.0.2015-07-034

  46. Kang R, Luo L, Chen H, Zhu Q, Liao L, Xing H, Zhu J, Shen Z, Lan G, Tang Z, Shao Y, Yang W, Ruan Y. Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study. BMJ Open. 2019;9(3):e025666. https://doi.org/10.1136/bmjopen-2018-025666.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Du X, He Q, Yang T, Wang Y, Xu H, Hao C, Zhou K, Gu J, Hao Y. Intention to start ART after the launch of expanded treatment strategy among people living with HIV in China: a behavioral theory-based cross-sectional study. AIDS Care. 2020;32(9):1182–90. https://doi.org/10.1080/09540121.2019.1686601.

    Article  PubMed  Google Scholar 

  48. Horter S, Wringe A, Thabede Z, Dlamini V, Kerschberger B, Pasipamire M, Lukhele N, Rusch B, Seeley J. “Is it making any difference?” A qualitative study examining the treatment-taking experiences of asymptomatic people living with HIV in the context of Treat-all in Eswatini. J Int AIDS Soc. 2019;22(1):e25220. https://doi.org/10.1002/jia2.25220.

  49. Hendrickson ZM, Naugle DA, Tibbels N, Dosso A, Van Lith ML, Mallalieu EC, Kamara D, DaillyAjavon P, Cisse A, SeifertAhanda K, Thaddeus S, Babalola S, Hoffmann CJ. “You Take Medications, You Live Normally”: The Role of Antiretroviral Therapy in Mitigating Men’s Perceived Threats of HIV in Côte d’Ivoire. AIDS Behav. 2019;23(9):2600–9. https://doi.org/10.1007/s10461-019-02614-5.

  50. Chapman Lambert C, Westfall A, Modi R, Amico RK, Golin C, Keruly J, Quinlivan EB, Crane HM, Zinski A, Turan B, Turan JM, Mugavero MJ. HIV-related stigma, depression, and social support are associated with health-related quality of life among patients newly entering HIV care. AIDS Care. 2020;32(6):681–8. https://doi.org/10.1080/09540121.2019.1622635.

    Article  PubMed  Google Scholar 

  51. Patel MS, Small DS, Harrison JD, Fortunato MP, Oon AL, Rareshide CAL, Reh G, Szwartz G, Guszcza J, Steier D, Kalra P, Hilbert V. Effectiveness of Behaviorally Designed Gamification Interventions With Social Incentives for Increasing Physical Activity Among Overweight and Obese Adults Across the United States: The STEP UP Randomized Clinical Trial. JAMA Intern Med. 2019;179(12):1624–32. https://doi.org/10.1001/jamainternmed.2019.3505.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Mgbako O, Benoit E, Iyengar NS, Kuhner C, Brinker D, Duncan DT. “Like a ticking time bomb”: the persistence of trauma in the HIV diagnosis experience among black men who have sex with men in New York City. BMC Public Health. 2020;20(1):1247. https://doi.org/10.1186/s12889-020-09342-9.

  53. Mwamba C, Beres LK, Topp SM, Mukamba N, Simbeza S, Sikombe K, Mody A, Geng E, Holmes CB, Kennedy CE, Sikazwe I, Denison JA, Bolton MC. I need time to start antiretroviral therapy’: understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia. Ann Med. 2022;54(1):830–6. https://doi.org/10.1080/07853890.2022.2051069.

  54. Tao J, Vermund SH, Lu H, Ruan Y, Shepherd BE, Kipp AM, Amico KR, Zhang X, Shao Y, Qian HZ. Impact of Depression and Anxiety on Initiation of Antiretroviral Therapy Among Men Who Have Sex with Men with Newly Diagnosed HIV Infections in China. AIDS Patient Care STDS. 2017;31(2):96–104. https://doi.org/10.1089/apc.2016.0214.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Yang T, Yang X, Li L, Xu H, Fan L, Li Q, Fan X, Chen W, Du X, Hao C, Li J, Hao Y, Gu J. HIV diagnosis period influences ART initiation: findings from a prospective cohort study in China. AIDS Res Ther. 2021;18(1):59. https://doi.org/10.1186/s12981-021-00379-3.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Seeley J, Bond V, Yang B, Floyd S, MacLeod D, Viljoen L, Phiri M, Simuyaba M, Hoddinott G, Shanaube K, Bwalya C, de Villiers L, Jennings K, Mwanza M, Schaap A, Dunbar R, Sabapathy K, Ayles H, Bock P, Hayes R, Fidler S, HPTN 071 (PopART). Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa. AIDS Behav. 2019;23(4):929–46. https://doi.org/10.1007/s10461-018-2335-7.

  57. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55(1):68–78. https://doi.org/10.1037//0003-066x.55.1.68.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not Applicable.

Funding

This work was supported by Sichuan Science and Technology Program (2020JDRC0138) in China. The funding party did not have any role in the design of the study and collection, analysis, and interpretation of data.

Author information

Authors and Affiliations

Authors

Contributions

MT, JT, YC, YZ, LX, WW, and XY jointly designed and developed the study, JT and YC designed the game, and MT drafted the protocol. YZ and LX will collect the data. WW and XY will analyze the data. All authors will regularly review the manuscript drafts and have approved the final version of the protocol.

Authors' information

Min Tian: 1,183,755,823@qq.com; Department of Orthopedics, The Affiliated Hospital of Southwest Medical University.

Yu Zheng: 1,500,838,808@qq.com; Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University.

Longsheng Xie: 522,742,738@qq.com; Department of Nephrology, Affiliated Hospital of Southwest Medical University.

Wei Wei: 1,074,641,881@qq.com;School of Nursing, Southwest Medical University.

Xingli Yu: 960,159,980@qq.com; Department of Operating Room, The Affiliated Hospital of Southwest Medical University.

Yanhua Chen: chen_yanhua25@163.com; Department of Nursing, The Affiliated Hospital of Southwest Medical University.

Jian Tang: tangjian034@swmu.edu.cn; Department of Operating Room, The Affiliated Hospital of Southwest Medical University. Department of Nursing, The Affiliated Hospital of Southwest Medical University.

Corresponding authors

Correspondence to Yanhua Chen or Jian Tang.

Ethics declarations

Ethics approval and consent to participate

The study has been approved by Ethics Committee of Clinical Trials, Affiliated Hospital of Southwest Medical University (KY2022163) in China. On-site consent will be provided to all participants.The data collected in this study will be published in papers after the study is completed.

Consent for publication

Not Applicable.

Competing interests

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, M., Zheng, Y., Xie, L. et al. Game-based health education to improve ART adherence of newly diagnosed young people with HIV: protocol for a stepped-wedge design randomized controlled trial. BMC Public Health 22, 2251 (2022). https://doi.org/10.1186/s12889-022-14708-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-14708-2

Keywords